Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Lupaxis
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Lupaxis 100mg prolonged-release tablets
0407020AGBEABAD
|
Lupaxis | Tapentadol | Central Nervous System | No data available |
|
Lupaxis 150mg prolonged-release tablets
0407020AGBEACAE
|
Lupaxis | Tapentadol | Central Nervous System | No data available |
|
Lupaxis 200mg prolonged-release tablets
0407020AGBEADAF
|
Lupaxis | Tapentadol | Central Nervous System | No data available |
|
Lupaxis 250mg prolonged-release tablets
0407020AGBEAEAG
|
Lupaxis | Tapentadol | Central Nervous System | No data available |
|
Lupaxis 50mg prolonged-release tablets
0407020AGBEAAAC
|
Lupaxis | Tapentadol | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.